Microba Life Sciences Ltd has released a press release.
Microba receives two AusIndustry Advanced Overseas Findings
Filed with ASX ·
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- Q3 FY23 Quarterly Investor Presentation
- Q3 FY23 Quarterly Activities Report & Appendix 4C
- SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia
- Microba Receives Ethics Approval for Phase 1 Clinical Trial
- SYNLAB Agreements Signed in Turkiye and Czech Republic
Later from Microba Life Sciences
- MRFF Grant Awarded to QUT, In Collaboration With Microba
- Microba Commences Phase I Clinical Trial for IBD Therapeutic
- First Distribution Agreement Executed with Sonic Healthcare
- Q4 FY23 Quarterly Activities Report & Appendix 4C
- Q4 FY23 Quarterly Investor Presentation
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences